Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

Andrew Lotery, Sobha Sivaprasad, Abby J O'Connell, Rosie A Harris, Lucy A Culliford, Lucy A Ellis, Angela Cree, Savita Madhusudan, Francine Behar-Cohen, Usha Chakravarthy, Tunde Peto, Chris A Rogers, Barnaby C Reeves

Research output: Contribution to journalArticle (Academic Journal)peer-review

38 Citations (Scopus)
56 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences